Your search history is turned on.
Date: February 23, 2015 Jurisdictions: Quebec
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2015 (February 20, 2015) NPS PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter) (908) 450-5300 (Registrants Telephone Number, Including Area Code) Check the a...
Microsoft Word - DisplayExhibit.aspx Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)* ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number 0-23272 ...
Date: February 19, 2015 Jurisdictions: Quebec
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number 0-23272 NPS PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter) 550 Hills D...
Microsoft Word - TOR_2024-#12761085-v1-2015_-_YE_-_MD&A_(Annual)_Letter_-_NPS_Pharmaceuticals_Inc_.docx 1 F V A R D I D D D T Y ( R S / 12761085.1 February 18, VIA SEDAR Autorit des Re: NPS Pha Dear Sirs/Me In accordanc Disclosure an Discussion a December 31 Type: Audite Yours truly, (sig...
Exhibit 31.2 RULE 13a-14(a)/15d-14(a) CERTIFICATION I, Luke M. Beshar, Senior Vice President and Chief Financial Officer, certify that: 1. I have reviewed this Annual Report on Form 10-K of NPS Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement...
Exhibit 31.1 RULE 13a-14(a)/15d-14(a) CERTIFICATION I, Francois Nader, President and Chief Executive Officer, certify that: 1. I have reviewed this Annual Report on Form 10-K of NPS Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in l...
Date: January 12, 2015 Jurisdictions: Quebec
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 11, 2015 Date of Report (Date of earliest event reported) NPS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) 550 Hills ...
Date: November 11, 2014 Jurisdictions: Quebec
Exhibit 31.2 RULE 13a-14(a)/15d-14(a) CERTIFICATION I, Luke M. Beshar, Executive Vice President and Chief Financial Officer, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NPS Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta...